BCM
CORZ icon

Bluefin Capital Management’s Core Scientific CORZ Stock Holding History

Bluefin Capital Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-102,273
Closed -$1.74M – 135
2025
Q4 		$1.49M Sell
102,273
-506,185
-83% -$8.83M 0.37% 39
2025
Q3 		$10.9M Buy
608,458
+509,100
+512% +$7.47M 3.49% 6
2025
Q2 		$1.7M Buy
+99,358
New +$994K 1.28% 17

Other funds holding CORZ

SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Bluefin Capital Management's CORZ Position: Q1 2026 in Review

Bluefin Capital Management sold out of Core Scientific (CORZ) in Q1 2026, closing a stake of 102,273 shares — an estimated $1.74M sold.

Bluefin Capital Management first reported a position in CORZ in Q2 2025 and held it in 3 quarters. The position peaked at $10.9M in Q3 2025. 386 funds tracked by Wall St. Rank hold CORZ as of Q1 2026.

  • Bluefin Capital Management reported no remaining Core Scientific position as of Q1 2026 after selling out during the quarter.
  • Bluefin Capital Management sold 102,273 Core Scientific shares in Q1 2026, an estimated $1.74M.
  • Bluefin Capital Management first reported a position in Core Scientific in Q2 2025 and held it in 3 quarters.
  • Bluefin Capital Management's Core Scientific position peaked at $10.9M in Q3 2025.
  • 386 funds tracked by Wall St. Rank held Core Scientific as of Q1 2026.

Based on Bluefin Capital Management's 13F filing for Q1 2026, filed 15 May 2026.